Inventor · disambiguated record
David M. Tellers
Also filed as: TELLERS DAVID · TELLERS DAVID M
22 granted patents·7 pending applications·64 citations·filing 2010–2022
93Inventor score
Files withSIRNA THERAPEUTICS INC12MERCK SHARP & DOHME7MERCK SHARP & DOHME LLC2AARONSON JEFFREY G1ACTON III JOHN J1
Top patents by PatentIndex Score
29 records- 0193US10512638B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2016·Granted Dec 24, 2019·8 cites·6 claims
- 0291US10689648B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 23, 2020·5 cites·19 claims
- 0388US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0488US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 0586US9540639B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted Jan 10, 2017·10 cites·22 claims
- 0684US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 0784US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 0884US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 0983US11530407B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·1 cites·25 claims
- 1083US8987377B2Poly(amide) polymers for the delivery of oligonucleotidesBARRETT STEPHANIE E·Filed 2011·Granted Mar 24, 2015·7 cites·18 claims
- 1182US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 1280US12486503B2Short interfering nucleic acid (siNA) compositionsSIRNA THERAPEUTICS INC·Filed 2022·Granted Dec 2, 2025·0 cites·18 claims
- 1378US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 1477US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 1576US8637449B2Processes for preparing protease inhibitors of hepatitis C virusSONG ZHIGUO JAKE·Filed 2010·Granted Jan 28, 2014·8 cites·26 claims
- 1674US10981902B25-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted Apr 20, 2021·1 cites·18 claims
- 1772US8691580B2Single chemical entities and methods for delivery of oligonucleotidesAARONSON JEFFREY G·Filed 2011·Granted Apr 8, 2014·2 cites·6 claims
- 1867US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 1961US2015299696A1SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONSCARR BRIAN ALLEN·Filed 2013·Application pending·0 cites
- 2059US2025051341A1Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2158US2017137815A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2255US2016074525A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2354US2013253168A1Novel single chemical entities and methods for delivery of oligonucleotidesCOLLETTI STEVEN L·Filed 2011·Application pending·0 cites
- 2449US11970479B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 30, 2024·0 cites·18 claims
- 2548US2023066268A1Indazole derivatives and methods of use thereof for the treatment of herpes virusesCOOKE ANDREW JOHN·Filed 2020·Application pending·0 cites
- 2647US10239957B2Peptide containing conjugates for dual molecular delivery of oligonucleotidesMERCK SHARP & DOHME·Filed 2014·Granted Mar 26, 2019·0 cites·1 claims
- 2746US10214742B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·0 cites·20 claims
- 2846US2015374844A1Novel ph -switchable peptides for membrane insertion and pore formationUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 2944US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →